Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial. Disclosures can be found at Neurology.org.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Neurology Podcast
2026 International Conference on Functional Neurological Disorder
Exploring Military Sexual Trauma and Migraine Among US Veterans
Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants
When Drug Marketing Masquerades as Clinical Trials
Get summaries like this every morning.
Free AI-powered recaps of Neurology Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.